SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-032649
Filing Date
2014-04-30
Accepted
2014-04-30 16:07:44
Documents
15
Period of Report
2014-04-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-10828_28k.htm 8-K 27584
2 EX-99.1 a14-10828_2ex99d1.htm EX-99.1 23524
3 EX-99.2 a14-10828_2ex99d2.htm EX-99.2 20138
4 GRAPHIC g108282mmi001.gif GRAPHIC 5356
5 GRAPHIC g108282moi001.gif GRAPHIC 166868
6 GRAPHIC g108282moi002.gif GRAPHIC 157814
7 GRAPHIC g108282moi003.jpg GRAPHIC 63049
8 GRAPHIC g108282moi004.jpg GRAPHIC 58682
9 GRAPHIC g108282moi005.jpg GRAPHIC 54524
10 GRAPHIC g108282moi006.gif GRAPHIC 103414
11 GRAPHIC g108282moi007.gif GRAPHIC 94470
12 GRAPHIC g108282moi008.gif GRAPHIC 67028
13 GRAPHIC g108282moi009.gif GRAPHIC 68213
14 GRAPHIC g108282moi010.gif GRAPHIC 58676
15 GRAPHIC g108282moi011.gif GRAPHIC 158847
  Complete submission text file 0001104659-14-032649.txt   1530444
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 14798748
SIC: 2834 Pharmaceutical Preparations